Olema Pharmaceuticals Inc expected to post a loss of 55 cents a share - Earnings Preview

Olema Pharmaceuticals

03/05/2024 12:50

* Olema Pharmaceuticals Inc  OLMA.OQ   OLMA.O  is expected
to show
no change in quarterly revenue when it reports  results on May 7
(estimated) for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for Olema Pharmaceuticals
Inc is
for a loss of 55 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Olema
Pharmaceuticals Inc is $24.50​, above​ its last closing price
of $10.07. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.48       -0.48      -0.49     Missed  -1.9
 Sep. 30 2023  -0.50       -0.51      -0.48     Beat    6.1
 Jun. 30 2023  -0.72       -0.73      -0.49     Beat    32.6​
 Mar. 31 2023  -0.71       -0.66      -0.70     Missed  -5.5
 ​​Dec.        -0.62       -0.65      -0.65     Met     0.3
 31 2022                                                
 Sep. 30 2022  -0.76       -0.77      -0.57     Beat    25.8​
 Jun. 30 2022  -0.65       -0.64      -0.82     Missed  -27.7
 Mar. 31 2022  -0.61       -0.57      -0.58     Missed  -1.8
 This summary was machine generated May 3 at 11:50 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)